Borouge IPO raises $2 billion
Recently, Borouge said it has completed the bookkeeping and public subscription process for its initial public offering (IPO) on the Abu Dhabi Stock Exchange (ADX). The company has confirmed that the previously announced issue size was just over 3 billion ordinary shares, equivalent to 10% of Borouge's total issued share capital, at AED 2.45 per share. Its parent companies, Abu Dhabi National Oil Company (ADNOC) and Borealis Middle East Holdings (Borealis ME), now have a combined financing of more than $2 billion at the time of settlement.
Borouge said the stock offering was "multiple" oversubscribed, with huge demand from UAE retail investors and accredited institutional investors. The company said the total demand for the IPO was more than $83.4 billion, implying a total subscription volume of 42 times the offering value. This is the largest public company in ADX's history. After the subscription period, the first tranche of the IPO will be set aside for UAE retail investors and other individual investors at 10%. The second tranche is reserved for local, regional and international qualified institutional investors, and the size is set at 88%, mainly for employees of ADNOC Group companies living in the UAE, Borealis employees living in the UAE, retirees of ADNOC and Borealis in the UAE . The third tranche retained by employees and retirees of other related companies is set at 2%.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
ADNOC to Transfer 24.9% of OMV to XRG
-
Borouge Announces Strategic Expansions to Increase Capacity
-
Borouge, ADNOC, Borealis and Wanhua Chemical explore Chinese polyolefins project
-
Siegwerk and Borouge to develop 100% recyclable single-material coating solution
-
Price increases drive sales growth! 2022 report cards of BASF, Dow, LG Chem, Borouge, etc. announced
-
Borouge IPO raises $2 billion
-
China’s Agrochemical Role Expands as Global Supply Risks Intensify
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
China’s Agrochemical Role Expands as Global Supply Risks Intensify
-
Dafeng Haijianuo’s RMB 246 Million Technical Revamp Project Takes Shape, with Multiple Production Lines for Vitamin K1, Folic Acid, and Others Under Construction
Recommend Reading
-
BASF Approves €1 Billion Share Buyback Program as Chemical Giant Prioritizes Capital Discipline
-
Evonik to Spin Off Infrastructure Operations into New Services Company SYNEQT
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
BASF and IFF Collaborate to Accelerate Innovation in Enzymes and Polymers
-
Borealis Commits Over €100 Million to New PP Compounds Line in Austria
-
Dichloromethane Stabilizes First, Then Collapses
-
March Aniline Market Rises Sharply in China
-
BDO Market in China Sees Slower Price Increase
-
Caustic Soda Prices Overall Decline in May
-
Recent Acetic Acid Market Prices Have Risen Significantly in China